Provention Bio is a clinical-stage biopharmaceutical company dedicated to sourcing, developing, and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. Their predict and prevent model is focused on developing novel therapeutic approaches that intervene before the target disease begins, re-appears, or progresses. Provention Bio offers the potential to reduce the high morbidity, mortality, patient suffering, and escalating costs of chronic autoimmune and inflammatory diseases, such as type 1 diabetes (T1D), Crohnâ??s disease, ulcerative colitis, and emerging viral infections. They believe Proventionâ??s business model, coupled with its expertise in translational medicine, immunology, and the design and execution of rapid go/no-go clinical trials, will enable them to in-license and efficiently partner both early-stage development assets and more advanced clinical-stage opportunities.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Provention Bio Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Provention Bio Inc market cap is $2.37B.
What is the 52-week high for Provention Bio Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Provention Bio Inc 52 week high is $25.00 as of September 15, 2025.
What is the 52-week low for Provention Bio Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Provention Bio Inc 52 week low is $3.19 as of September 15, 2025.
What is Provention Bio Inc stock price today?
Provention Bio Inc stock price today is $24.98.
What was Provention Bio Inc stock price yesterday?
Provention Bio Inc stock price yesterday was $24.23.
What is the PE ratio of Provention Bio Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Provention Bio Inc’s P/E ratio is -16.32.
What is the Price-to-Book ratio of Provention Bio Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Provention Bio Inc P/B ratio is 17.9725.
What is the 50-day moving average of Provention Bio Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Provention Bio Inc 50-day moving average is $18.81.